SURPASS CVOT: Dual Incretin Therapy Cuts Cardiorenal Events
5:28
SURPASS CVOT: Dual Incretin Therapy Cuts Cardiorenal Events
14 views2 weeks ago
YouTubeDocWire
NEJM on Instagram: "In patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide with respect to major cardiovascular events. ⁣ ⁣ Read the full SURPASS-CVOT trial results and Research Summary at NEJM.org (link in bio). ⁣ ⁣ #Endocrinology #Cardiology #NEJM"
1:15
NEJM on Instagram: "In patients with type 2 diabetes and atheroscl…
151.9K views4 months ago
Instagramnejm
Original Article: Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes (SURPASS-CVOT)
1:16
Original Article: Cardiovascular Outcomes with Tirzepatide in Typ…
3.1K views4 months ago
YouTubeNEJM Group
SURPASS-CVOT: Tirzepatide vs. Dulaglutide in cardiorenal outcomes 🔎 What was evaluated?
2:29
SURPASS-CVOT: Tirzepatide vs. Dulaglutide in cardiorenal outcom…
1K views1 month ago
YouTubeAfya Cardiopapers
AHA 25: SURPASS-CVOT:Tirzepatide vs Dulaglutide for Heart Failure in T2D
12:44
AHA 25: SURPASS-CVOT:Tirzepatide vs Dulaglutide f…
1K views5 months ago
YouTubeRadcliffe Cardiology
Tirzepatide Demonstrates Cardiovascular Protection: Results of the Surpass-Cvot Study
9:31
Tirzepatide Demonstrates Cardiovascular Protection: Result…
476 views7 months ago
YouTubeAboutPharma
Tirzepatide vs Dulaglutide for Cardiovascular Outcomes (SURPASS-CVOT) | NEJM | Med Journal Club
11:27
Tirzepatide vs Dulaglutide for Cardiovascular Outcomes (SURP…
475 views4 months ago
YouTubeMed Journal Club
9:29
EASD 2025: SURPASS-CVOT - A Comparison of Tirzepatide and Du…
188 views3 months ago
YouTubeEuropean Association for the Study of Diabetes
15:49
SURPASS CVOT: Dr. Deepak Bhatt Breaks Down Tirzepatide CV Data
145 views3 months ago
YouTubeDocWire
2:42
Does mounjaro give same, or better cardiovascular protection, than tr…
27 views1 week ago
YouTubedrsuepedersen
3:26
Frias_Tirzepatide: Overview of SURPASS Trials in Patients With T…
1.4K viewsFeb 6, 2023
YouTubeCardiometabolic Health Congress (CMHC)
2:28
SURPASS CVOT - EASD 2025
264 views7 months ago
YouTubeDr. Enrique Morales
Tirzepatide vs Dulaglutide in T2D: SURPASS-CVOT - Prof. Dr. Stephe…
1 month ago
YouTubeMARKUS at HOMe
10:14
Does Mounjaro Prevent Heart Attacks? Docs React to New Study
2.6K views9 months ago
YouTubeDr. Spencer Nadolsky
11:59
Azione antidiabete, riduzione del peso corporeo e cardioprotezione…
1.2K views9 months ago
YouTubePharmaStarTV
6:38
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis
891 viewsMar 13, 2025
YouTubeRadcliffe Cardiology
5:19
Dr. Ruben Mesa on the SURPASS-ET Trial and Unmet Needs in Esse…
409 views11 months ago
YouTubeBlood Cancers Today
4:22
SURPASS CVOT - EASD 2025
76 views6 months ago
YouTubeAbeso - Associação Brasileira para o Estudo d…
How SURPASS-CVOT Spotlights Tirzepatide for Cardiovascular Out…
Jul 28, 2023
ajmc.com
1:59
SURPASS ET: ropeginterferon versus anagrelide as second line t…
1.4K viewsJan 24, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
49:39
Training on SurPASS 3
2.3K viewsDec 11, 2020
YouTubeAMLCICF KSU
35:37
Dec 19 2025 This Week in Cardiology
703 views4 months ago
YouTubeMedscape
1:21
Comparing ropeginterferon alfa-2b to anagrelide in ET: topline result…
165 views10 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:52
Topline results from the SURPASS-ET trial: ropeginterferon alfa-2b ve…
136 views10 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:46
SURPASS-3 Explained 🚨 New Benchmark for Type 2 Diabetes C…
15 views1 month ago
YouTubeDocplexus
1:52
Join John McMurray as he discusses the SURPASS-CVOT Tri…
4.6K views5 months ago
FacebookEuropean Society of Cardiology
11:15
SURPASS Trial to Investigate Promising Monoclonal Antibody f…
27 views4 months ago
YouTubeBlood Cancers Today
Tirzepatide Outperforms Dulaglutide in Cardiorenal Outcomes, With Ste…
3 weeks ago
hcplive.com
8:14
Tirzepatide versus Semaglutide in Type 2 Diabetes (SURPASS-2) | N…
10.5K viewsJun 28, 2021
YouTubeMed Journal Club
36:59
Associations between GLP-1 Receptor Agonists and Ischemic …
1 day ago
YouTubeAmerican Diabetes Association
See more videos
Static thumbnail place holder